Shoulder Innovations, Inc. (SI) Insider Trading

Last 12 months

Insiders bought $215k and sold $1.03M on the open market.

82% of the selling was scheduled in advance under 10b5-1 plans.

Net open-market

−$812k

5 buys · 3 sales

Under a 10b5-1 plan

82%

of the value sold

Insiders who bought / sold

3 / 2

executives and directors

Last open-market buy

Mar 2026

Mar 13, 2026

Get an email when SI's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 14	Robert Joseph Ball CEO & Executive Chairman	SoldNo plan	10,175	$18.45	$188k	2.6%	Form 4
Aug 26	Gilde Healthcare Holding B.v. Large holder	SoldNo plan	1,196	$22.60	$27k	<0.1%	Form 4
Aug 20 – 24	Gilde Healthcare Holding B.v. Large holder	SoldNo plan 3 parts	25,097	$22.61 average	$567k	1.1%	Form 4
Aug 17 – 18	Matthew Fraser Ahearn Chief Operating Officer	Sold10b5-1 plan 3 parts	22,500	$20.66 average	$465k	8.4%	Form 4
Aug 5 – 6	Gilde Healthcare Holding B.v. Large holder	SoldNo plan 2 parts	9,433	$22.63 average	$213k	0.4%	Form 4
Aug 3 – 4	Gilde Healthcare Holding B.v. Large holder	SoldNo plan 2 parts	110,563	$22.76 average	$2.52M	4.7%	Form 4
Jul 30 – 31	Gilde Healthcare Holding B.v. Large holder	SoldNo plan 2 parts	48,279	$23.10 average	$1.12M	2.0%	Form 4
Jun 12 – 15	Matthew Fraser Ahearn Chief Operating Officer	Sold10b5-1 plan 3 parts	20,000	$18.71 average	$374k	6.9%	Form 4
Mar 13	Robert Joseph Ball CEO & Executive Chairman	Bought	2,200	$15.18	$33k	0.8%	Form 4
Mar 13	Richard Buchholz Director	Bought	1,000	$14.84	$15k	7.9%	Form 4
Mar 13	Jeffrey S. Points Chief Financial Officer	Bought	2,000	$15.00	$30k	2.9%	Form 4
Dec 11, 2025 – Dec 12, 2025	Jeffrey S. Points Chief Financial Officer	Bought 2 parts	2,000	$14.82 average	$30k	3.8%	Form 4
Dec 11, 2025 – Dec 12, 2025	Robert Joseph Ball CEO & Executive Chairman	Bought 2 parts	7,200	$14.86 average	$107k	6.5%	Form 4
Sep 12, 2025	Jeffrey S. Points CHIEF FINANCIAL OFFICER	Bought	1,600	$15.67	$25k	3.1%	Form 4
Sep 11, 2025 – Sep 12, 2025	Robert Joseph Ball CEO & EXECUTIVE CHAIRMAN	Bought 2 parts	8,000	$15.34 average	$123k	7.7%	Form 4
Aug 1, 2025	Casey M Tansey Director	Bought	40,000	$15.00	$600k	1.5%	Form 4
Aug 1, 2025	Jeffrey S. Points CHIEF FINANCIAL OFFICER	Bought	50	$15.00	$750	0.1%	Form 4
Aug 1, 2025	Geoffrey B Pardo Director	Bought	100,000	$15.00	$1.5M	4.4%	Form 4
Aug 1, 2025	Lightstone Ventures II (a), L.p. Large holder	Bought	266,666	$15.00	$4M	16%	Form 4
Aug 1, 2025	Michael A Carusi Director	Bought	266,666	$15.00	$4M	16%	Form 4
Aug 1, 2025	Richard Buchholz Director	Bought	5,000	$15.00	$75k	65%	Form 4
Aug 1, 2025	Gilde Healthcare Holding B.v. Large holder	Bought	100,000	$15.00	$1.5M	4.4%	Form 4

Sep 14No plan
Robert Joseph Ball
CEO & Executive Chairman · sold 10,175 at $18.45
$188k
2.6% of stake
Aug 26No plan
Gilde Healthcare Holding B.v.
Large holder · sold 1,196 at $22.60
$27k
<0.1% of stake
Aug 20 – 24No plan
Gilde Healthcare Holding B.v.
Large holder · sold 25,097 at avg $22.61
$567k
1.1% of stake
Aug 17 – 1810b5-1 plan
Matthew Fraser Ahearn
Chief Operating Officer · sold 22,500 at avg $20.66
$465k
8.4% of stake
Aug 5 – 6No plan
Gilde Healthcare Holding B.v.
Large holder · sold 9,433 at avg $22.63
$213k
0.4% of stake
Aug 3 – 4No plan
Gilde Healthcare Holding B.v.
Large holder · sold 110,563 at avg $22.76
$2.52M
4.7% of stake
Jul 30 – 31No plan
Gilde Healthcare Holding B.v.
Large holder · sold 48,279 at avg $23.10
$1.12M
2.0% of stake
Jun 12 – 1510b5-1 plan
Matthew Fraser Ahearn
Chief Operating Officer · sold 20,000 at avg $18.71
$374k
6.9% of stake
Mar 13
Robert Joseph Ball
CEO & Executive Chairman · bought 2,200 at $15.18
$33k
0.8% of stake
Mar 13
Richard Buchholz
Director · bought 1,000 at $14.84
$15k
7.9% of stake
Mar 13
Jeffrey S. Points
Chief Financial Officer · bought 2,000 at $15.00
$30k
2.9% of stake
Dec 11, 2025 – Dec 12, 2025
Jeffrey S. Points
Chief Financial Officer · bought 2,000 at avg $14.82
$30k
3.8% of stake
Dec 11, 2025 – Dec 12, 2025
Robert Joseph Ball
CEO & Executive Chairman · bought 7,200 at avg $14.86
$107k
6.5% of stake
Sep 12, 2025
Jeffrey S. Points
CHIEF FINANCIAL OFFICER · bought 1,600 at $15.67
$25k
3.1% of stake
Sep 11, 2025 – Sep 12, 2025
Robert Joseph Ball
CEO & EXECUTIVE CHAIRMAN · bought 8,000 at avg $15.34
$123k
7.7% of stake
Aug 1, 2025
Casey M Tansey
Director · bought 40,000 at $15.00
$600k
1.5% of stake
Aug 1, 2025
Jeffrey S. Points
CHIEF FINANCIAL OFFICER · bought 50 at $15.00
$750
0.1% of stake
Aug 1, 2025
Geoffrey B Pardo
Director · bought 100,000 at $15.00
$1.5M
4.4% of stake
Aug 1, 2025
Lightstone Ventures II (a), L.p.
Large holder · bought 266,666 at $15.00
$4M
16% of stake
Aug 1, 2025
Michael A Carusi
Director · bought 266,666 at $15.00
$4M
16% of stake
Aug 1, 2025
Richard Buchholz
Director · bought 5,000 at $15.00
$75k
65% of stake
Aug 1, 2025
Gilde Healthcare Holding B.v.
Large holder · bought 100,000 at $15.00
$1.5M
4.4% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch SI, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Surgical & Medical Instruments & Apparatus

LNSRLensar Inc.

CVRXCVRx, Inc.

VEROVenus Concept Inc.

CARLCarlsmed, Inc.

APYXApyx Medical Corporation

SSIISS Innovations International, Inc.

KRMDKoru Medical Systems Inc.

TLSITriSalus Life Sciences Inc.

Spot a number that looks wrong? Check it in SI's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing SI

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.